Evofem Biosciences, Inc. Gains 27.76%
Thu, Jun 29, 2023 at 11:52 PM
Evofem Biosciences, Inc. (EVFM:NASDAQ) jumped higher at $0.92, representing a gain of 27.8%. The stock got featured on our News Catalysts scanner on Fri, Jun 16, 2023 at 06:41 PM in the 'EARNINGS' category. From Fri, Jun 16, 2023, the stock recorded 25.00% Up Days and 55.56% Green Days
About Evofem Biosciences, Inc. (EVFM:NASDAQ)
Neothetics Inc is a clinical-stage pharmaceutical company developing therapeutics for the aesthetic market. Its product is a novel injectable treatment for the reduction of central abdominal bulging due to subcutaneous fat in non-obese patients.
Top 10 Gainers:
- Sigilon Therapeutics Inc. (SGTX:NASDAQ), 440.92%
- Advanced Human Imaging Limited. (AHI:NASDAQ), 300%
- Eco Wave Power Global AB (publ) (WAVE:NASDAQ), 57.05%
- Kintara Therapeutics Inc. (KTRA:NASDAQ), 40.8%
- Zhong Yang Financial Group Limited (TOP:NASDAQ), 38.05%
- The Greenbrier Companies, Inc. (GBX:NYSE), 31.84%
- Fangdd Network Group Ltd. (DUO:NASDAQ), 31.17%
- Immunome Inc. (IMNM:NASDAQ), 30.29%
- Evofem Biosciences, Inc. (EVFM:NASDAQ), 27.76%
- Franklin Covey Co. (FC:NYSE), 26.28%